ACTIVE

TERVEST

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

220,8 k €

-3.7% YoY

Gross margin

508,5 k €

-1.8% YoY

Equity

2,5 M €

+9.7% YoY

Workforce

1,2 ETP

+20.0% YoY

What does TERVEST do?

TERVEST is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Tervuren. It employs on average 1,2 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0500.522.275

Incorporation

29/10/2012

Legal form

Private limited company

Registered office

Sterrebeeklaan 32
3080 Tervuren · FlandreSee on map

Contributed capital

789 000,00 €

Latest accounts

30/06/2025

Average workforce

1,2 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 70200Management consultancy activities 70220Business and other management consultancy activities

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 13 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013
Income statement
Gross margin	508,5 k €	-1.8%	517,8 k €	+10.5%	468,6 k €	+7.1%	437,7 k €	-15.7%	519,1 k €	+53.3%	338,7 k €	-32.8%	504,2 k €	+36.9%	368,4 k €	+107%	177,6 k €	+181%	63,1 k €	+181%	22,5 k €	+543%	-5,1 k €	-9.5%	-4,6 k €
EBITDA	432,6 k €	-3.9%	450,3 k €	+13.3%	397,6 k €	+10.4%	360,3 k €	-22.9%	467,6 k €	+61.8%	288,9 k €	-36.5%	455,2 k €	+44.8%	314,3 k €	+112%	147,9 k €	+138%	62,2 k €	+182%	22,1 k €	+508%	-5,4 k €	-1.7%	-5,3 k €
Operating result	353,1 k €	-6.8%	378,8 k €	+9.9%	344,6 k €	+0.2%	343,8 k €	-25.6%	462 k €	+60.3%	288,3 k €	-36.6%	454,6 k €	+44.8%	313,9 k €	+113%	147,5 k €	+138%	62 k €	+181%	22,1 k €	+508%	-5,4 k €	-1.7%	-5,3 k €
Net result	220,8 k €	-3.7%	229,2 k €	+6.7%	214,8 k €	-2.2%	219,6 k €	-26.1%	297,1 k €	+84.7%	160,8 k €	-43.1%	282,4 k €	+31.8%	214,3 k €	+115%	99,8 k €	+142%	-235,4 k €	-1492%	16,9 k €	+350%	-6,8 k €	-10.0%	-6,1 k €
Balance sheet
Equity	2,5 M €	+9.7%	2,3 M €	+11.2%	2 M €	+11.7%	1,8 M €	+13.6%	1,6 M €	+22.6%	1,3 M €	+13.9%	1,2 M €	+32.4%	871,7 k €	+32.6%	657,4 k €	+17.9%	557,6 k €	-29.7%	793 k €	+2.2%	776,1 k €	+1219%	58,9 k €
Total assets	4,4 M €	+0.9%	4,3 M €	+2.2%	4,2 M €	+16.6%	3,6 M €	+5.3%	3,5 M €	+11.4%	3,1 M €	+3.2%	3 M €	+13.9%	2,6 M €	+7.5%	2,5 M €	+0.3%	2,4 M €	+180%	873,2 k €	+2.8%	849,2 k €	+589%	123,3 k €
Cash	265,8 k €	+64.3%	161,8 k €	-35.2%	249,8 k €	-25.7%	336,4 k €	+70.8%	197 k €	+37.7%	143 k €	+564%	21,5 k €		–		–		–		–		–		–
Debts	1,9 M €	-8.8%	2,1 M €	-6.2%	2,2 M €	+21.6%	1,8 M €	-2.1%	1,8 M €	+3.1%	1,8 M €	-3.4%	1,9 M €	+4.7%	1,8 M €	-1.6%	1,8 M €	-4.9%	1,9 M €	+2305%	78,6 k €	+9.8%	71,6 k €	+13.7%	62,9 k €
Other
Workforce	1,2 ETP	+20.0%	1,0 ETP	-16.7%	1,2 ETP	-14.3%	1,4 ETP	+40.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	+42.9%	0,7 ETP		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 2 ended

Active mandates

Kris Haemels

Director · since 29 octobre 2012

Active

Ilse Jonckheere

Director

Active

Ended mandates

Ilse Jonckheere

Manager · since 29 octobre 2012

Ended

Kris Haemels

Manager · since 29 octobre 2012

Ended

At this address

Other companies at this address

Company	CBE no.
APOTHEEK HAEMELS● Active	0880.313.206
KRITO PHARMA● Active	0500.718.255

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	12/02/2026	31/01/2025	30/01/2024	24/01/2023	27/01/2022	29/01/2021
General meeting	28/11/2025	29/11/2024	25/11/2023	16/12/2022	17/12/2021	18/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

13 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	28/11/2025	12/02/2026	Dutch	PDF
Abridged model	30/06/2024	29/11/2024	31/01/2025	Dutch	PDF
Abridged model	30/06/2023	25/11/2023	30/01/2024	Dutch	PDF
Abridged model	30/06/2022	16/12/2022	24/01/2023	Dutch	PDF
Abridged model	30/06/2021	17/12/2021	27/01/2022	Dutch	PDF
Abridged model	30/06/2020	18/12/2020	29/01/2021	Dutch	PDF
Abridged model	30/06/2019	20/12/2019	20/02/2020	Dutch	PDF
Abridged model	30/06/2018	21/12/2018	21/01/2019	Dutch	PDF
Abridged model	30/06/2017	24/11/2017	30/11/2017	Dutch	PDF
Abridged model	30/06/2016	25/11/2016	16/02/2017	Dutch	PDF
Abridged model	30/06/2015	27/11/2015	22/12/2015	Dutch	PDF
Abridged model	30/06/2014	19/12/2014	19/01/2015	Dutch	PDF
Abridged model	30/06/2013	20/12/2013	20/02/2014	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 2 ended

Active mandates

Kris Haemels

Director · since 29 octobre 2012

Active

Ilse Jonckheere

Director

Active

Ended mandates

Ilse Jonckheere

Manager · since 29 octobre 2012

Ended

Kris Haemels

Manager · since 29 octobre 2012

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates06/12/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares03/12/2013
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Other14/11/2012
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025220,8 k €↓
2024
Annual accounts 2024229,2 k €↑
2023
Annual accounts 2023214,8 k €↓
2022
Annual accounts 2022219,6 k €↓
2021
Annual accounts 2021297,1 k €↑
2020
Annual accounts 2020160,8 k €↓
2019
Annual accounts 2019282,4 k €↑
2018
Annual accounts 2018214,3 k €↑
2017
Annual accounts 201799,8 k €↑
2016
Annual accounts 2016-235,4 k €↓
2015
Annual accounts 201516,9 k €↑
2014
Annual accounts 2014-6,8 k €↓
2013
Annual accounts 2013-6,1 k €
29/10/2012
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

TERVEST

Overview

What does TERVEST do?

Trend over 13 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline